Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy

Multiple system atrophy (MSA) is a fatal neurodegenerative disorder characterized by the pathological accumulation of alpha-synuclein (α-syn) in oligodendrocytes. Therapeutic efforts to stop or delay the progression of MSA have yielded suboptimal results in clinical trials, and there are no efficien...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Acta Neuropathol Commun
Päätekijät: Valera, Elvira, Spencer, Brian, Fields, Jerel A., Trinh, Ivy, Adame, Anthony, Mante, Michael, Rockenstein, Edward, Desplats, Paula, Masliah, Eliezer
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217191/
https://ncbi.nlm.nih.gov/pubmed/28057080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-016-0409-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia